4/26/2022 Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109473
4/25/2022 Virtual care use during the COVID-19 pandemic and its impact on healthcare utilization in patients with chronic disease: a population-based repeated cross-sectional study Stamenova V, Chu C, Pang A, Fang J, Shakeri A, Cram P, Bhattacharyya O, Bhatia RS, Tadrous M. PLoS One. 2022; 17(4):e0267218. Epub 2022 Apr 25. DOI: https://doi.org/10.1371/journal.pone.0267218
4/14/2022 Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109459
Radio Canada2/22/2022Article More people are turning to melatonin to sleep. But experts say it’s not a panacea for everyone
CBC10/15/2020Article Ontario family doctors warn early supply drying up as they see surge in demand for flu shot